NCT06633003

Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: ALPS Biotech CO. LTD · Industry
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This study aims to assess the effect of Antrodia cinnamomea on clinical symptoms in spinocerebellar ataxia patients. To investigate the advancements in neurodegenerative diseases.

Detailed description

This study aims to assess the effect of Antrodia cinnamomea on clinical symptoms in spinocerebellar ataxia patients: a randomized, double-blind, placebo-controlled crossover design, and parallel clinical investigation.

Conditions

• Spinocerebellar Ataxia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Antrodia cinnamomea Products	Placebo-controlled crossover design: * Dietary Supplement: Antrodia Cinnamomea Products * Dietary Supplement: Placebo
DIETARY_SUPPLEMENT	Antrodia cinnamomea Products	A arm : Stage I : • Dietary Supplement: Antrodia Cinnamomea Products Stage II: • Dietary Supplement: Placebo B arm : Stage I : • Dietary Supplement: Placebo Stage II: • Dietary Supplement: Antrodia Cinnamomea Products

Timeline

• Start date: 2024-09-16
• Primary completion: 2027-08-31
• Completion: 2027-08-31
• First posted: 2024-10-09
• Last updated: 2024-12-10

Locations

1 site across 1 country: Taiwan